Table of Contents

Select this article
- R G Hankard,
- M W Haymond,
- and D Darmaun
Role of glutamine as a glucose precursor in fasting humans.
Diabetes October 1997 46:1535-1541; doi:10.2337/diabetes.46.10.1535
- Abstract
Select this article
- X D Yang,
- H K Sytwu,
- H O McDevitt,
- and S A Michie
Involvement of beta 7 integrin and mucosal addressin cell adhesion molecule-1 (MAdCAM-1) in the development of diabetes in obese diabetic mice.
Diabetes October 1997 46:1542-1547; doi:10.2337/diabetes.46.10.1542
- Abstract
Select this article
- W Karges,
- D Hammond-McKibben,
- R Gaedigk,
- N Shibuya,
- R Cheung,
- and H M Dosch
Loss of self-tolerance to ICA69 in nonobese diabetic mice.
Diabetes October 1997 46:1548-1556; doi:10.2337/diabetes.46.10.1548
- Abstract
Select this article
- J Rachman,
- J C Levy,
- B A Barrow,
- S E Manley,
- and R C Turner
Relative hyperproinsulinemia of NIDDM persists despite the reduction of hyperglycemia with insulin or sulfonylurea therapy.
Diabetes October 1997 46:1557-1562; doi:10.2337/diabetes.46.10.1557
- Abstract
Select this article
- H M Kubisch,
- J Wang,
- T M Bray,
- and J P Phillips
Targeted overexpression of Cu/Zn superoxide dismutase protects pancreatic beta-cells against oxidative stress.
Diabetes October 1997 46:1563-1566; doi:10.2337/diabetes.46.10.1563
- Abstract
Select this article
- T Kobayashi,
- K Nakanishi,
- H Nakase,
- H Kajio,
- M Okubo,
- T Murase,
- and K Kosaka
In situ characterization of islets in diabetes with a mitochondrial DNA mutation at nucleotide position 3243.
Diabetes October 1997 46:1567-1571; doi:10.2337/diabetes.46.10.1567
- Abstract
Select this article
- S J Koopmans,
- L Ohman,
- J R Haywood,
- L J Mandarino,
- and R A DeFronzo
Seven days of euglycemic hyperinsulinemia induces insulin resistance for glucose metabolism but not hypertension, elevated catecholamine levels, or increased sodium retention in conscious normal rats.
Diabetes October 1997 46:1572-1578; doi:10.2337/diabetes.46.10.1572
- Abstract
Select this article
- B H Goodpaster,
- F L Thaete,
- J A Simoneau,
- and D E Kelley
Subcutaneous abdominal fat and thigh muscle composition predict insulin sensitivity independently of visceral fat.
Diabetes October 1997 46:1579-1585; doi:10.2337/diabetes.46.10.1579
- Abstract
Select this article
- Y T Kruszynska,
- M I Mulford,
- J G Yu,
- D A Armstrong,
- and J M Olefsky
Effects of nonesterified fatty acids on glucose metabolism after glucose ingestion.
Diabetes October 1997 46:1586-1593; doi:10.2337/diabetes.46.10.1586
- Abstract
Select this article
- J B Meigs,
- R B D'Agostino, Sr,
- P W Wilson,
- L A Cupples,
- D M Nathan,
- and D E Singer
Risk variable clustering in the insulin resistance syndrome. The Framingham Offspring Study.
Diabetes October 1997 46:1594-1600; doi:10.2337/diabetes.46.10.1594
- Abstract
Select this article
- G Romano,
- L Patti,
- F Innelli,
- L Di Marino,
- G Annuzzi,
- M Iavicoli,
- G A Coronel,
- G Riccardi,
- and A A Rivellese
Insulin and sulfonylurea therapy in NIDDM patients. Are the effects on lipoprotein metabolism different even with similar blood glucose control?
Diabetes October 1997 46:1601-1606; doi:10.2337/diabetes.46.10.1601
- Abstract
Select this article
- O Schnell,
- B Eisfelder,
- E Standl,
- and A G Ziegler
High-dose intravenous insulin infusion versus intensive insulin treatment in newly diagnosed IDDM.
Diabetes October 1997 46:1607-1611; doi:10.2337/diabetes.46.10.1607
- Abstract
Select this article
- T J Allen,
- Z Cao,
- S Youssef,
- U L Hulthen,
- and M E Cooper
Role of angiotensin II and bradykinin in experimental diabetic nephropathy. Functional and structural studies.
Diabetes October 1997 46:1612-1618; doi:10.2337/diabetes.46.10.1612
- Abstract
Select this article
- R S Punglia,
- M Lu,
- J Hsu,
- M Kuroki,
- M J Tolentino,
- K Keough,
- A P Levy,
- N S Levy,
- M A Goldberg,
- R J D'Amato,
- and A P Adamis
Regulation of vascular endothelial growth factor expression by insulin-like growth factor I.
Diabetes October 1997 46:1619-1626; doi:10.2337/diabetes.46.10.1619
- Abstract
Select this article
- N Sekiguchi,
- F Umeda,
- M Masakado,
- Y Ono,
- T Hashimoto,
- and H Nawata
Immunohistochemical study of prostacyclin-stimulating factor (PSF) in the diabetic and atherosclerotic human coronary artery.
Diabetes October 1997 46:1627-1632; doi:10.2337/diabetes.46.10.1627
- Abstract
Select this article
- N Sakane,
- T Yoshida,
- K Yoshioka,
- Y Nakamura,
- T Umekawa,
- A Kogure,
- Y Takakura,
- and M Kondo
Beta 3-adrenoreceptor gene polymorphism: a newly identified risk factor for proliferative retinopathy in NIDDM patients.
Diabetes October 1997 46:1633-1636; doi:10.2337/diabetes.46.10.1633
- Abstract
Select this article
- T Awata,
- S Kurihara,
- C Kikuchi,
- S Takei,
- I Inoue,
- C Ishii,
- K Takahashi,
- K Negishi,
- Y Yoshida,
- R Hagura,
- Y Kanazawa,
- and S Katayama
Evidence for association between the class I subset of the insulin gene minisatellite (IDDM2 locus) and IDDM in the Japanese population.
Diabetes October 1997 46:1637-1642; doi:10.2337/diabetes.46.10.1637
- Abstract
Select this article
- S Yamada,
- H Nishigori,
- H Onda,
- T Utsugi,
- T Yanagawa,
- T Maruyama,
- K Onigata,
- K Nagashima,
- R Nagai,
- A Morikawa,
- T Takeuchi,
- and J Takeda
Identification of mutations in the hepatocyte nuclear factor (HNF)-1 alpha gene in Japanese subjects with IDDM.
Diabetes October 1997 46:1643-1647; doi:10.2337/diabetes.46.10.1643
- Abstract
Select this article
- C Gragnoli,
- T Lindner,
- B N Cockburn,
- P J Kaisaki,
- F Gragnoli,
- G Marozzi,
- and G I Bell
Maturity-onset diabetes of the young due to a mutation in the hepatocyte nuclear factor-4 alpha binding site in the promoter of the hepatocyte nuclear factor-1 alpha gene.
Diabetes October 1997 46:1648-1651; doi:10.2337/diabetes.46.10.1648
- Abstract
Select this article
- H Furuta,
- N Iwasaki,
- N Oda,
- Y Hinokio,
- Y Horikawa,
- K Yamagata,
- N Yano,
- J Sugahiro,
- M Ogata,
- H Ohgawara,
- Y Omori,
- Y Iwamoto,
- and G I Bell
Organization and partial sequence of the hepatocyte nuclear factor-4 alpha/MODY1 gene and identification of a missense mutation, R127W, in a Japanese family with MODY.
Diabetes October 1997 46:1652-1657; doi:10.2337/diabetes.46.10.1652
- Abstract
- P M Hansen,
- T Chowdhury,
- T Deckert,
- A Hellgren,
- S C Bain,
- and F Pociot
Genetic variation of the heparan sulfate proteoglycan gene (perlecan gene). Association with urinary albumin excretion in IDDM patients.
Diabetes October 1997 46:1658-1659
- M J MacDonald,
- L J Brown,
- N M Hasan,
- M Stoffel,
- and D G Dills
Single-stranded conformational polymorphism analysis of the mitochondrial glycerol phosphate dehydrogenase gene in NIDDM.
Diabetes October 1997 46:1660-1661

Diabetes

Role of glutamine as a glucose precursor in fasting humans.

Involvement of beta 7 integrin and mucosal addressin cell adhesion molecule-1 (MAdCAM-1) in the development of diabetes in obese diabetic mice.

Loss of self-tolerance to ICA69 in nonobese diabetic mice.

Relative hyperproinsulinemia of NIDDM persists despite the reduction of hyperglycemia with insulin or sulfonylurea therapy.

Targeted overexpression of Cu/Zn superoxide dismutase protects pancreatic beta-cells against oxidative stress.

In situ characterization of islets in diabetes with a mitochondrial DNA mutation at nucleotide position 3243.

Seven days of euglycemic hyperinsulinemia induces insulin resistance for glucose metabolism but not hypertension, elevated catecholamine levels, or increased sodium retention in conscious normal rats.

Subcutaneous abdominal fat and thigh muscle composition predict insulin sensitivity independently of visceral fat.

Effects of nonesterified fatty acids on glucose metabolism after glucose ingestion.

Risk variable clustering in the insulin resistance syndrome. The Framingham Offspring Study.

Insulin and sulfonylurea therapy in NIDDM patients. Are the effects on lipoprotein metabolism different even with similar blood glucose control?

High-dose intravenous insulin infusion versus intensive insulin treatment in newly diagnosed IDDM.

Role of angiotensin II and bradykinin in experimental diabetic nephropathy. Functional and structural studies.

Regulation of vascular endothelial growth factor expression by insulin-like growth factor I.

Immunohistochemical study of prostacyclin-stimulating factor (PSF) in the diabetic and atherosclerotic human coronary artery.

Beta 3-adrenoreceptor gene polymorphism: a newly identified risk factor for proliferative retinopathy in NIDDM patients.

Evidence for association between the class I subset of the insulin gene minisatellite (IDDM2 locus) and IDDM in the Japanese population.

Identification of mutations in the hepatocyte nuclear factor (HNF)-1 alpha gene in Japanese subjects with IDDM.

Maturity-onset diabetes of the young due to a mutation in the hepatocyte nuclear factor-4 alpha binding site in the promoter of the hepatocyte nuclear factor-1 alpha gene.

Organization and partial sequence of the hepatocyte nuclear factor-4 alpha/MODY1 gene and identification of a missense mutation, R127W, in a Japanese family with MODY.

Genetic variation of the heparan sulfate proteoglycan gene (perlecan gene). Association with urinary albumin excretion in IDDM patients.

Single-stranded conformational polymorphism analysis of the mitochondrial glycerol phosphate dehydrogenase gene in NIDDM.

This Issue

Current Issue